Plante Moran Financial Advisors’s Vir Biotechnology VIR Stock Holding History

Plante Moran Financial Advisors’s Portfolio VIR Stock Details VIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$387	Buy	+38	New	+$362	﹤0.01%	1213

Other funds holding VIR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

SAI

Savvy Advisors Inc New York $4.71B AUM 25.36% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

APMC

Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return

Plante Moran Financial Advisors's VIR Position: Q2 2026 in Review

Plante Moran Financial Advisors opened a new position in Vir Biotechnology (VIR) in Q2 2026: 38 shares worth $387. The stake represents ﹤0.01% of the portfolio and ranks #1213 among its holdings.

89 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

Plante Moran Financial Advisors held 38 shares of Vir Biotechnology worth $387 as of Q2 2026.
Vir Biotechnology was a new Plante Moran Financial Advisors position in Q2 2026.
Vir Biotechnology made up ﹤0.01% of Plante Moran Financial Advisors's portfolio in Q2 2026, its #1213 holding.
89 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Plante Moran Financial Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.